Page last updated: 2024-08-21

adamantane and Glucose Intolerance

adamantane has been researched along with Glucose Intolerance in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (35.71)29.6817
2010's7 (50.00)24.3611
2020's2 (14.29)2.80

Authors

AuthorsStudies
Chiheb, S; Cosson, E; Fysekidis, M; Rezki, A; Valensi, P; Vicaut, E2
Hemmingsen, B; Metzendorf, MI; Richter, B; Sonne, DP1
Chen, Q; Huang, L; Kong, L; Wang, J; Wang, Z; Xu, D; Zhang, T; Zhou, X1
Iwamura, T; Kainoh, M; Kawai, K; Kumagai, H; Nakaki, J; Nitta, A; Okazaki, S; Sakami, S; Sato, M; Sekiya, Y; Takahashi, T; Yagi, M1
Buzzetti, R; Frederich, R; Hirshberg, B; Iqbal, N; Pozzilli, P1
Ito, H; Mimori, N; Sekiguchi, K; Wajima, T; Yamaguchi, M1
Inaba, W; Kamata, K; Mizukami, H; Takahashi, K; Tsuboi, K; Yagihashi, S1
Döller, D; Frantal, S; Haidinger, M; Hecking, M; Lechner, F; Pacini, G; Pleiner, J; Säemann, MD; Stemer, G; Werzowa, J1
Balkan, B; Bolognese, L; Burkey, BF; Hughes, TE; Li, X; Mone, M; Russell, M; Wang, PR1
Inoue, T; Kira, K; Nagakura, T; Saeki, T; Shinoda, M; Tanaka, I; Yamazaki, K; Yasuda, N1
Aerts, JM; Aten, J; Dubbelhuis, PF; Grefhorst, A; Kuipers, F; O'Rahilly, S; Ottenhoff, R; Overkleeft, HS; Powlson, AS; Serlie, MJ; Sethi, JK; van Eijk, M; Wennekes, T1
Deacon, CF; Foley, JE; Gerchman, F; Holst, JJ; Kahn, SE; Ligueros-Saylan, MA; Marcovina, SM; Montgomery, B; Tong, J; Udayasankar, J; Utzschneider, KM; Watson, CE1
Baron, MA; Deacon, CF; Foley, JE; Holst, JJ; Landin-Olsson, M; Rendell, M; Rochotte, E; Rosenstock, J1

Reviews

1 review(s) available for adamantane and Glucose Intolerance

ArticleYear
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
    The Cochrane database of systematic reviews, 2017, 05-10, Volume: 5

    Topics: Adamantane; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Fasting; Glucagon-Like Peptide 1; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Liraglutide; Metformin; Nitriles; Peptides; Pyrrolidines; Randomized Controlled Trials as Topic; Risk Factors; Venoms; Vildagliptin

2017

Trials

7 trial(s) available for adamantane and Glucose Intolerance

ArticleYear
Acute and long-term effects of saxagliptin on post-prandial glycemic response in obese patients with impaired glucose tolerance.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2021, 04-09, Volume: 31, Issue:4

    Topics: Adamantane; Adult; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; France; Glucose Intolerance; Humans; Male; Middle Aged; Obesity; Pilot Projects; Postprandial Period; Time Factors; Treatment Outcome

2021
Acute and long-term effects of saxagliptin on a set of cardiovascular targets measured at fasting and post-prandially in obese patients with impaired glucose tolerance: A placebo-controlled study.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2021, 09-22, Volume: 31, Issue:10

    Topics: Adamantane; Adult; Biomarkers; Blood Glucose; Cardiovascular System; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; France; Glucose Intolerance; Humans; Male; Middle Aged; Obesity; Pilot Projects; Postprandial Period; Time Factors; Treatment Outcome; Vagus Nerve

2021
Effects of saxagliptin on glucose homeostasis and body composition of obese patients with newly diagnosed pre-diabetes.
    Diabetes research and clinical practice, 2017, Volume: 130

    Topics: Adamantane; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Diet; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucose Intolerance; Homeostasis; Humans; Insulin Resistance; Life Style; Male; Metformin; Middle Aged; Obesity; Postprandial Period; Prediabetic State; Treatment Outcome

2017
Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).
    Diabetes/metabolism research and reviews, 2016, Volume: 32, Issue:3

    Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucose Intolerance; Humans; Latent Autoimmune Diabetes in Adults; Male; Middle Aged; Young Adult

2016
Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial.
    Transplantation, 2013, Feb-15, Volume: 95, Issue:3

    Topics: Adamantane; Aged; Blood Glucose; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kidney Transplantation; Male; Middle Aged; Nitriles; Outcome Assessment, Health Care; Pioglitazone; Pyrrolidines; Risk Factors; Thiazolidinediones; Treatment Outcome; Vildagliptin

2013
The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose.
    Diabetes care, 2008, Volume: 31, Issue:1

    Topics: Adamantane; Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Nitriles; Placebos; Pyrrolidines; Single-Blind Method; Vildagliptin

2008
Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
    Diabetes care, 2008, Volume: 31, Issue:1

    Topics: Adamantane; Blood Glucose; C-Peptide; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Humans; Inulin; Kinetics; Male; Nitriles; Placebos; Postprandial Period; Pyrrolidines; Vildagliptin

2008

Other Studies

6 other study(ies) available for adamantane and Glucose Intolerance

ArticleYear
HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 351, Issue:1

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adamantane; Administration, Oral; Animals; Azepines; Carbenoxolone; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Obesity; Pioglitazone; Thiazolidinediones; Triazoles

2014
[Preclinical and clinical findings of the dipeptidyl peptidase-4 inhibitor vildagliptin].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2010, Volume: 136, Issue:5

    Topics: Adamantane; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucose Intolerance; Humans; Hypoglycemic Agents; Incretins; Insulin Resistance; Islets of Langerhans; Nitriles; Pyrrolidines; Vildagliptin

2010
Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.
    European journal of pharmacology, 2012, Sep-15, Volume: 691, Issue:1-3

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adamantane; Animals; Apoptosis; Cell Proliferation; Deoxyguanosine; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Eating; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Nitriles; Pyrrolidines; Rats; Time Factors; Vildagliptin

2012
Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:2

    Topics: Adamantane; Animals; Area Under Curve; Blood Glucose; Dietary Fats; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Glucagon-Like Peptide 1; Glucose Intolerance; Glucose Oxidase; Glucose Tolerance Test; Insulin Resistance; Male; Nitriles; Pyrrolidines; Rats; Rats, Zucker; Tachyphylaxis; Time Factors; Vildagliptin; Weight Gain

2005
7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one is a novel competitive and selective inhibitor of dipeptidyl peptidase IV with an antihyperglycemic activity.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:3

    Topics: Adamantane; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Fats; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Dose-Response Relationship, Drug; Glucagon-Like Peptide 1; Glucose Intolerance; Glucose Tolerance Test; Hypoglycemic Agents; Imidazoles; Insulin; Kinetics; Mice; Mice, Inbred C57BL; Nitriles; Piperazines; Protease Inhibitors; Purines; Pyridazines; Pyrrolidines; Rats; Rats, Zucker; Tosyl Compounds; Vildagliptin

2006
Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity.
    Diabetes, 2007, Volume: 56, Issue:5

    Topics: 1-Deoxynojirimycin; 3T3 Cells; Adamantane; Adipocytes; Animals; Ceramides; Enzyme Inhibitors; Glucose Intolerance; Glucosylceramides; Glucosyltransferases; Glycosphingolipids; Humans; Insulin; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Pancreas; Signal Transduction

2007